Cargando…

Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer

Bladder cancer is one of the most common urothelial tumors worldwide. While there are some progresses on early bladder cancer detection, patients’ mortalities have not been changed significantly. So it is important to get further understanding the mechanism involved in the development and progressio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Mingwei, Li, Jianfa, Zhuang, Chengle, Cai, Zhiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438641/ https://www.ncbi.nlm.nih.gov/pubmed/28157695 http://dx.doi.org/10.18632/oncotarget.14945

Ejemplares similares

Theophylline controllable RNAi-based genetic switches regulate expression of lncRNA TINCR and malignant phenotypes in bladder cancer cells
por: Chen, Zhicong, et al.
Publicado: (2016)

ABHD11-AS1: An Emerging Long Non-Coding RNA (lncRNA) with Clinical Significance in Human Malignancies
por: Golla, Upendarrao, et al.
Publicado: (2022)

LncRNA NRON promotes the proliferation, metastasis and EMT process in bladder cancer
por: Xiong, Tiefu, et al.
Publicado: (2020)

Synthetic Tet-inducible artificial microRNAs targeting β-catenin or HIF-1α inhibit malignant phenotypes of bladder cancer cells T24 and 5637
por: Zhan, Yonghao, et al.
Publicado: (2015)

Author Correction: Synthetic Tet-inducible artificial microRNAs targeting β-catenin or HIF-1α inhibit malignant phenotypes of bladder cancer cells T24 and 5637
por: Zhan, Yonghao, et al.
Publicado: (2023)

Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer
por: He, Anbang, et al.
Publicado: (2016)

LncRNA ABHD11‐AS1 promotes the development of endometrial carcinoma by targeting cyclin D1
por: Liu, Yao, et al.
Publicado: (2018)

Circulating lncRNA ABHD11-AS1 serves as a biomarker for early pancreatic cancer diagnosis
por: Liu, Yawen, et al.
Publicado: (2019)

Knockdown of lncRNA ABHD11-AS1 Suppresses the Tumorigenesis of Pancreatic Cancer via Sponging miR-1231
por: Liu, Bowei, et al.
Publicado: (2020)

Role of the lncRNA ABHD11-AS(1) in the tumorigenesis and progression of epithelial ovarian cancer through targeted regulation of RhoC
por: Wu, Dan-Dan, et al.
Publicado: (2017)

lncRNA ABHD11‐AS1, regulated by the EGFR pathway, contributes to the ovarian cancer tumorigenesis by epigenetically suppressing TIMP2
por: Zeng, Xiang‐Yang, et al.
Publicado: (2019)

shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells
por: Li, Jianfa, et al.
Publicado: (2016)

LncRNA ABHD11-AS1 Participates in the Progression of Cervical Carcinoma by Targeting miR-1254 and Is the Key to the Diagnosis and Treatment of Cervical Carcinoma in the Future
por: Zhu, Duanrong, et al.
Publicado: (2022)

Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells
por: Zhuang, Chengle, et al.
Publicado: (2015)

Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer
por: Li, Jianfa, et al.
Publicado: (2016)

Correction: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer
por: Li, Jianfa, et al.
Publicado: (2023)

LncRNA SNHG1 Facilitates Tumor Proliferation and Represses Apoptosis by Regulating PPARγ Ubiquitination in Bladder Cancer
por: Cai, Hongzhou, et al.
Publicado: (2022)

LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA
por: Chen, Mingwei, et al.
Publicado: (2020)

Artificial small RNA for sequence specific cleavage of target RNA through RNase III endonuclease Dicer
por: Xu, Wen, et al.
Publicado: (2016)

Synthetic regulatory RNAs selectively suppress the progression of bladder cancer
por: Zhuang, Chengle, et al.
Publicado: (2017)

Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-β/Smad Signaling
por: Zhuang, Changshui, et al.
Publicado: (2020)

Correction for: LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA
por: Chen, Mingwei, et al.
Publicado: (2021)

Corrigendum: Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-β/Smad Signaling
por: Zhuang, Changshui, et al.
Publicado: (2021)

BMSC-derived exosomal lncRNA PTENP1 suppresses the malignant phenotypes of bladder cancer by upregulating SCARA5 expression
por: Liu, Shu-Cheng, et al.
Publicado: (2022)

LncRNA HOXA11‐AS promotes hepatocellular carcinoma progression by repressing miR‐214‐3p
por: Zhan, Meixiao, et al.
Publicado: (2018)

Truncated Isoforms of lncRNA ANRIL Are Overexpressed in Bladder Cancer, But Do Not Contribute to Repression of INK4 Tumor Suppressors
por: Hoffmann, Michèle J., et al.
Publicado: (2015)

LncRNA PACER is down-regulated in osteoarthritis and regulates chondrocyte apoptosis and lncRNA HOTAIR expression
por: Jiang, Mingwei, et al.
Publicado: (2019)

LncRNA FLAIL affects alternative splicing and represses flowering in Arabidopsis
por: Jin, Yu, et al.
Publicado: (2023)

Proximity-dependent recruitment of Polycomb repressive complexes by the lncRNA Airn
por: Braceros, Aki K., et al.
Publicado: (2023)

Immunomodulatory lysophosphatidylserines are regulated by ABHD16A and ABHD12 interplay
por: Kamat, Siddhesh S., et al.
Publicado: (2015)

A CRISPR Interference of CBP and p300 Selectively Induced Synthetic Lethality in Bladder Cancer Cells In Vitro
por: Li, Jianfa, et al.
Publicado: (2019)

lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells
por: Liu, Zhiping, et al.
Publicado: (2022)

Differential Expression of LncRNA in Bladder Cancer Development
por: Spirito, Lorenzo, et al.
Publicado: (2023)

lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA‐150
por: Luo, Huarong, et al.
Publicado: (2019)

lncRNA-mediated ceRNA network in bladder cancer
por: Li, Kun, et al.
Publicado: (2022)

LncRNA MALAT1 Inhibits Apoptosis and Promotes Invasion by Antagonizing miR-125b in Bladder Cancer Cells
por: Xie, Haibiao, et al.
Publicado: (2017)

Transcriptional repression of lncRNA and miRNA subsets mediated by LRF during erythropoiesis
por: Athanasopoulou, Katerina, et al.
Publicado: (2023)

Construction of an lncRNA model for prognostic prediction of bladder cancer
por: Shi, Changlong, et al.
Publicado: (2022)

A pyroptosis‐related lncRNA signature in bladder cancer
por: Wang, Peng, et al.
Publicado: (2022)

LncRNA PTCSC3 Alleviates the Postoperative Distant Recurrence of Gastric Cancer by Suppression of lncRNA HOXA11-AS
por: Xu, Jiapeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hk7qte7jpmctbfspusp7kbn6br